Castle Biosciences Quote - CSTL

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

27.53

Bid

27.50

Ask

45.00

Volume

382,571

26.58 Day's Range 27.99

16.965 52 Week Range 35.6973

Market Cap

771.041M

Previous Close

27.09

Open

26.58

Last Trade

264

27.53

(priorref)

Last Trade Time

Financial Volume

US$ 10,325,510

VWAP

26.9898

Average Volume (3m)

382,382

Shares Outstanding

28,007,301

Dividend Yield

PE Ratio

-13.41

Earnings Per Share (EPS)

-2.05

Revenue

219.79M

Net Profit

-57.47M

Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.castlebiosciences.com

Headquarters

Wilmington, Delaware, USA

Founded

Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was US$27.09. Over the last year, Castle Biosciences shares have traded in a share price range of US$ 16.965 to US$ 35.6973.

Castle Biosciences currently has 28,007,301 shares outstanding. The market capitalization of Castle Biosciences is US$758.72 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -13.41.

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on Dec. 13, 2024, the Compensation Committee of its...

Independent Systematic Review and Meta-Analysis Attests to the Significant Risk Stratification Provided by Castle Biosciences’ DecisionDx®-Melanoma Test, Contributing to Personalized Management of Patients with Melanoma

This recently published meta-analysis encompasses 13 peer-reviewed publications involving thousands of patients and affirms the powerful risk stratification provided by DecisionDx-Melanoma and...

Form 4 - Statement of changes in beneficial ownership of securities

Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a...

Form 4 - Statement of changes in beneficial ownership of securities

Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fourth Consecutive Year

Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional Development Castle...

Form 144 - Report of proposed sale of securities

Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, will share new data highlighting the clinical performance of its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.58	-5.4276880797	29.11	29.72	26.3	262057	27.86116047	CS
4	-1.71	-5.84815321477	29.24	32.6	26.3	307434	29.94131307	CS
12	-0.44	-1.57311405077	27.97	35.6973	26.3	382382	31.20071577	CS
26	5.43	24.5701357466	22.1	35.6973	16.965	397044	27.65245573	CS
52	6.57	31.3454198473	20.96	35.6973	16.965	320036	25.61151392	CS
156	-13.28	-32.5410438618	40.81	48.4	9.2601	312956	23.36573638	CS
260	0.33	1.21323529412	27.2	107.69	9.2601	276067	33.81984275	CS

CSTL - Frequently Asked Questions (FAQ)

What is the current Castle Biosciences share price?

The current share price of Castle Biosciences is US$ 27.53

How many Castle Biosciences shares are in issue?

Castle Biosciences has 28,007,301 shares in issue

What is the market cap of Castle Biosciences?

The market capitalisation of Castle Biosciences is USD 758.72M

What is the 1 year trading range for Castle Biosciences share price?

Castle Biosciences has traded in the range of US$ 16.965 to US$ 35.6973 during the past year

What is the PE ratio of Castle Biosciences?

The price to earnings ratio of Castle Biosciences is -13.41

What is the cash to sales ratio of Castle Biosciences?

The cash to sales ratio of Castle Biosciences is 3.51

What is the reporting currency for Castle Biosciences?

Castle Biosciences reports financial results in USD

What is the latest annual turnover for Castle Biosciences?

The latest annual turnover of Castle Biosciences is USD 219.79M

What is the latest annual profit for Castle Biosciences?

The latest annual profit of Castle Biosciences is USD -57.47M

What is the registered address of Castle Biosciences?

The registered address for Castle Biosciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Castle Biosciences website address?

The website address for Castle Biosciences is www.castlebiosciences.com

Which industry sector does Castle Biosciences operate in?

Castle Biosciences operates in the MEDICAL LABORATORIES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	281.23M